EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A

Marijn L van den Berg iD, Dirk-Jan van Beek iD, Medard F M van den Broek, Lutske Lodewijk, Annemarie A Verrijn Stuart, Sheila C E J Terwisscha van Scheltinga, Rachel S van Leeuwaarde, Inne H M Borel Rinkes, Menno R Vriens

Endocrine-Related Cancer · 2026

DOI: 10.1530/erc-25-0366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Marijn L van den Berg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Calcitonin, Thyroid Neoplasms, Thyroidectomy, Multiple Endocrine Neoplasia Type 2a. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroidectomy is recommended for patients with multiple endocrine neoplasia type 2A (MEN2A). American Thyroid Association 2015 guidelines recommend follow-up of calcitonin values after thyroidectomy. The aim of this study was to determine the natural course of calcitonin levels after total thyroidectomy (TTx) in MEN2A patients. Patients with MEN2A who underwent TTx between 1993 and 2019 and had multiple postoperative calcitonin measurements were retrospectively included from our referral center. Long-term serial calcitonin measurements and clinical outcomes were correlated to the first postoperative calcitonin, histopathology and type of TTx (prophylactic versus non-prophylactic). Fifty-two patients underwent TTx after 1993 at a median age of 10 years (range 0–71). Of these, 23 (44%) had no MTC and 29 (56%) had MTC. The median follow-up time was 12 years (range 3–30). Thirty-eight patients had an ‘undetectable’ first postoperative calcitonin, seven ‘within reference range’ and seven ‘above reference range’. Of the 38 patients with an ‘undetectable’ first postoperative calcitonin, 32 remained ‘undetectable’. All 21 patients without MTC and ‘undetectable’ first postoperative calcitonin remained ‘undetectable’. Of the 17 patients with MTC and ‘undetectable’ first postoperative calcitonin, 11 remained ‘undetectable’ and none developed structural recurrence. Twenty-two of the 25 patients undergoing prophylactic thyroidectomy had repeated ‘undetectable’ measurements. Persistent MTC or structural recurrence occurred in six patients; all had MTC, had a detectable first postoperative calcitonin and underwent non-prophylactic TTx. In conclusion, the long-term serial calcitonin values remain undetectable in the majority of the patients with an undetectable first postoperative calcitonin. Biochemical follow-up for patients without MTC and an undetectable first postoperative calcitonin may not be necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcitoninThyroid NeoplasmsThyroidectomyMultiple Endocrine Neoplasia Type 2aCarcinoma, NeuroendocrineHumansMaleFemaleAdultMiddle AgedAdolescentAgedChildYoung AdultChild, PreschoolInfantRetrospective Studies

Stichwörter der Autor:innen

MEN2Acalcitoninmedullary thyroid carcinomaprophylactic thyroidectomyrecurrencethyroidectomy

Substanzen

Calcitonin

Autor:innen und Institutionen

  • Department of Endocrine Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
  • Department of Pediatric Surgery, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.

ORCID-Profile: Marijn L van den Berg, Dirk-Jan van Beek

Zitieren

APA

van den Berg, M. L., van Beek, D. J., van den Broek, M. F. M., Lodewijk, L., Verrijn Stuart, A. A., Terwisscha van Scheltinga, S. C. E. J., van Leeuwaarde, R. S., Borel Rinkes, I. H. M., & Vriens, M. R. (2026). Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0366

Vancouver

van den Berg ML, van Beek DJ, van den Broek MFM, Lodewijk L, Verrijn Stuart AA, Terwisscha van Scheltinga SCEJ, et al. Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0366

BibTeX
@article{vandenBerg2026,
  author = {van den Berg, Marijn L and van Beek, Dirk-Jan and van den Broek, Medard F M and Lodewijk, Lutske and Verrijn Stuart, Annemarie A and Terwisscha van Scheltinga, Sheila C E J and van Leeuwaarde, Rachel S and Borel Rinkes, Inne H M and Vriens, Menno R},
  title = {Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-25-0366}
}
Kostenlos starten →